Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2025-04-28 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
公司2025年度董事、监事薪酬方案
Remuneration Information Classification · 95% confidence The document is a detailed description of the 2025 remuneration scheme for the company's directors and supervisors, including salary standards, principles, and organizational management. It does not contain financial statements, audit results, or regulatory certifications. It is not an announcement of a report but a standalone report on remuneration policy. This matches the definition of Remuneration Information (DEF 14A). The document length is short but contains substantive content on compensation, not just an announcement or summary.
2025-04-28 Chinese
董事会对独立董事独立性评估的专项意见
Governance Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules. The content focuses on the evaluation of independent directors' independence and compliance with governance rules. It is not a full annual report, audit report, or financial statement. It is a governance-related disclosure about board members' independence, which fits best under Governance Information (CGR). The document length is short and contains a specific report on governance matters, not just an announcement or certification, so it is not RNS or RPA.
2025-04-28 Chinese
独立董事2024年度述职报告 （赵克辉）
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2024, detailing the director's duties, attendance at board and committee meetings, communication with internal audit and accounting firms, oversight of financial reports, internal controls, and governance matters. It is a detailed narrative report on the director's activities and governance oversight rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements or audit opinions but focuses on board/management information and governance. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 4271 characters, which is sufficient for a detailed report but not a full annual report or audit report. No indication of it being a proxy, voting result, or regulatory filing is present.
2025-04-28 Chinese
2024年年度财务报告
Annual Report Classification · 95% confidence The document is titled as a financial report of 绿康生化股份有限公司 and contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity. The presence of comprehensive financial data such as assets, liabilities, revenues, expenses, and cash flows for the fiscal year 2024 and 2023 indicates this is a full financial performance report. The length of the document (15,000 characters) and the detailed financial tables confirm it is not a brief announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K) as it covers the company's full financial performance for the year. FY 2024
2025-04-28 Chinese
关于补选公司非独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a non-independent director to the company's board, including details about the resignation of a previous director and the nomination of a new candidate. It references board meetings, committee compositions, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly pertains to changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report publication.
2025-04-28 Chinese
立信会计事务所关于营业收入扣除情况专项报告
Audit Report / Information Classification · 95% confidence The document is titled as a "营业收入扣除情况鉴证报告" which translates to "Assurance Report on Deduction of Operating Revenue" for the year 2024. It is issued by a certified public accounting firm and includes an auditor's assurance opinion on the company's operating revenue deduction schedule. The document references auditing standards and regulatory requirements from the Shenzhen Stock Exchange. It contains detailed financial data related to revenue deductions but is primarily an auditor's assurance report on a specific financial schedule rather than a full annual or interim financial report. The document length is 2352 characters, which is relatively short and focused on the audit assurance of a specific financial aspect. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit assurance report on a particular financial matter, not a full annual report or interim report. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.